Literature DB >> 33005564

Evaluation of serum immunoglobulin (IgG, IgM, IgA) in potentially malignant disorders of oral cavity - A case control study.

Vivek M Tarsariya1, Dhaval N Mehta2, Nilesh Raval3, Hiren H Patadiya4, Kanan Vachhrajani5, Albert Ashem6.   

Abstract

BACKGROUND: Only few studies have been done to evaluate level of serum immunoglobulins (IgG,IgM,IgA) in patients with Potentially Malignant Disorders (PMD) like Leukoplakia, Oral Submucous Fibrosis (OSMF) and Oral Lichen Planus (OLP) as tumour markers. AIMS AND
OBJECTIVES: To estimate the serum immunoglobulins level (IgG, IgM, IgA) in leukoplakia, OSMF and oral lichen planus (OLP) patients and its comparison with levels among control groups and Weather these values can be used to predict severity of disease or not.
MATERIALS AND METHODS: 30 patients with different potentially malignant disorders like leukoplakia, OSMF and oral lichen planus and 30 healthy controls were selected at random and subjected for analysis of serum IgG, IgA, IgM. Statistical methods employed were mean, standard deviation and ANOVA test.
RESULTS: We observed significant elevated levels of all the immunoglobulins in leukoplakia, OSMF and oral lichen planus when compared with the control group and levels were increasing with clinical stages of OSMF (p < 0.05).
CONCLUSIONS: All these immunoglobulins are indicative of tumour burden or transformation of malignancy in higher stage and might be employed as prognostic indicators in these disorders.
© 2020 Craniofacial Research Foundation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  IgA; IgG; IgM; Potentially malignant disorder; Serum immunoglobulin; Tumour marker

Year:  2020        PMID: 33005564      PMCID: PMC7511741          DOI: 10.1016/j.jobcr.2020.09.002

Source DB:  PubMed          Journal:  J Oral Biol Craniofac Res        ISSN: 2212-4268


  20 in total

1.  Salivary coagulopathy and humoral response in oral submucous fibrosis (OSMF).

Authors:  V N Chatuvedi; A K Sharma; S Chakrabarati
Journal:  J Indian Dent Assoc       Date:  1991-03

Review 2.  Proposed clinical definition for oral submucous fibrosis.

Authors:  Chandramani B More; Naman R Rao
Journal:  J Oral Biol Craniofac Res       Date:  2019-07-02

3.  Oral submucous fibrosis in children and adolescents: Analysis of 36 cases.

Authors:  Chandramani Bhagwan More; Naman R Rao; Rahul Hegde; Rahi M Brahmbhatt; Ashish Shrestha; Gyanendra Kumar
Journal:  J Indian Soc Pedod Prev Dent       Date:  2020 Apr-Jun

4.  Serum immunoglobulins in head & neck cancer: effect of radiotherapy.

Authors:  G S Kohli; S P Yadav; D Chowdhry; H C Mehta
Journal:  Indian J Cancer       Date:  1987-03       Impact factor: 1.224

5.  The effects of radiotherapy on the immune system of patients with nasopharyngeal carcinoma.

Authors:  D E Hu; X S Ling; J Hu; B L Li; X F Wang; Y G Shen; J Ye
Journal:  Br J Radiol       Date:  1988-04       Impact factor: 3.039

6.  Evaluation of circulating immune complexes and serum immunoglobulins in oral cancer patients--a follow up study.

Authors:  Sameena Parveen; Neeraj Taneja; Renuka J Bathi; A C Deka
Journal:  Indian J Dent Res       Date:  2010 Jan-Mar

Review 7.  Clinical features and presentation of oral potentially malignant disorders.

Authors:  Saman Warnakulasuriya
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2018-04-04

Review 8.  Cancer biomarkers - current perspectives.

Authors:  Anant Narayan Bhatt; Rohit Mathur; Abdullah Farooque; Amit Verma; B S Dwarakanath
Journal:  Indian J Med Res       Date:  2010-08       Impact factor: 2.375

9.  Distribution of immunoglobulins in squamous cell carcinoma of the head and neck.

Authors:  C Neuchrist; J Kornfehl; M Grasl; H Lassmann; D Kraft; K Ehrenberger; O Scheiner
Journal:  Int Arch Allergy Immunol       Date:  1994-05       Impact factor: 2.749

10.  Oral cancer statistics in India on the basis of first report of 29 population-based cancer registries.

Authors:  Swati Sharma; L Satyanarayana; Smitha Asthana; K K Shivalingesh; Bala Subramanya Goutham; Sujatha Ramachandra
Journal:  J Oral Maxillofac Pathol       Date:  2018 Jan-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.